The global pharmaceutical landscape has entered a new phase of uncertainty after the United States imposed a steep 100% tariff on imported patented drugs. Announced under […]
India’s pharmaceutical industry—often called the “pharmacy of the world”—is facing an unexpected and critical challenge. A shortage of liquefied petroleum gas (LPG), a key industrial fuel, […]
Allergies are no longer seasonal inconveniences—they have become year-round health concerns for millions of Indians. From dust allergies and pollen sensitivity to food reactions and skin […]
Union Budget 2026, unveiled by Finance Minister Nirmala Sitharaman, put a strong spotlight on healthcare, especially with the ambitious Biopharma SHAKTI scheme — a transformative initiative […]
Diabetes has emerged as one of the most critical public health challenges in India, creating a strong and ever-growing demand for high-quality, affordable, and innovative diabetic […]
As the Indian pharmaceutical industry stands on the cusp of a major regulatory shift, the revised Schedule M norms are set to be enforced as scheduled, […]
India’s pharmaceutical industry has long been celebrated as the “pharmacy of the world,” a key supplier of generic medicines across the globe. However, this reputation has […]
The Indian pharmaceutical sector is once again in the global spotlight, and this time Wockhardt is leading the charge. In a remarkable market performance, Wockhardt’s share […]
In a deeply troubling turn of events, India’s drug regulator has moved swiftly in response to a spate of child fatalities linked to contaminated cough syrups. […]